doi: 10.3390/ijms26041651
Such statements include, but are not limited to, statements regarding Hims & Hers ability to expand internationally and serve customers around the globe, and any assumptions relating to the foregoing
We saw about a 30% increase in GLP-1 cost. HR Director, large manufacturer Many focus group participants reported that their firms will no longer cover GLP-1 agonists for weight loss due to the increases in use and costs
Ozempic is strictly for type 2 diabetes management, while Wegovy is explicitly developed for chronic weight management
How do I report a suspected side effect from retatrutide in the UK
Here, additional data on the preventive health benefits of treating obesity will be key (e.g., SELECT trial for semaglutide) A company with asset(s) featuring compelling preclinical and clinical data demonstrating the above described profile could be positioned well to raise venture capital, even in todays challenging private financing market, and attract M&A activity from giants like Novo Nordisk and Eli Lilly
